ADK_HUMAN - dbPTM
ADK_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ADK_HUMAN
UniProt AC P55263
Protein Name Adenosine kinase
Gene Name ADK
Organism Homo sapiens (Human).
Sequence Length 362
Subcellular Localization Isoform 1: Nucleus .
Isoform 2: Cytoplasm .
Protein Description ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides..
Protein Sequence MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKAAEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKARVCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGNETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFAVLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPDFH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAAEEEPK
------CCCCCCCCC
18.5122814378
34 (in isoform 2)Ubiquitination-6.0721906983
42UbiquitinationDISAVVDKDFLDKYS
EHHEEECHHHHHHCC
38.48-
47UbiquitinationVDKDFLDKYSLKPND
ECHHHHHHCCCCCCC
38.60-
47AcetylationVDKDFLDKYSLKPND
ECHHHHHHCCCCCCC
38.6020167786
48PhosphorylationDKDFLDKYSLKPNDQ
CHHHHHHCCCCCCCC
20.9224732914
49PhosphorylationKDFLDKYSLKPNDQI
HHHHHHCCCCCCCCC
35.3424719451
51 (in isoform 1)Ubiquitination-35.5221906983
51UbiquitinationFLDKYSLKPNDQILA
HHHHCCCCCCCCCCC
35.5221906983
54 (in isoform 2)Ubiquitination-45.4821906983
612-HydroxyisobutyrylationDQILAEDKHKELFDE
CCCCCHHHHHHHHHH
48.35-
61AcetylationDQILAEDKHKELFDE
CCCCCHHHHHHHHHH
48.3526822725
61UbiquitinationDQILAEDKHKELFDE
CCCCCHHHHHHHHHH
48.35-
632-HydroxyisobutyrylationILAEDKHKELFDELV
CCCHHHHHHHHHHHH
62.95-
63UbiquitinationILAEDKHKELFDELV
CCCHHHHHHHHHHHH
62.95-
71 (in isoform 1)Ubiquitination-66.1821906983
71UbiquitinationELFDELVKKFKVEYH
HHHHHHHHHCCEEEE
66.1821906983
712-HydroxyisobutyrylationELFDELVKKFKVEYH
HHHHHHHHHCCEEEE
66.18-
74AcetylationDELVKKFKVEYHAGG
HHHHHHCCEEEECCC
42.9326051181
77PhosphorylationVKKFKVEYHAGGSTQ
HHHCCEEEECCCCCH
10.4321963049
82PhosphorylationVEYHAGGSTQNSIKV
EEEECCCCCHHHHHH
26.3828152594
83PhosphorylationEYHAGGSTQNSIKVA
EEECCCCCHHHHHHH
34.7420068231
86PhosphorylationAGGSTQNSIKVAQWM
CCCCCHHHHHHHHHH
17.6120068231
111UbiquitinationFGCIGIDKFGEILKR
HHHEEEHHHHHHHHH
54.04-
117UbiquitinationDKFGEILKRKAAEAH
HHHHHHHHHHHHHHH
58.47-
160S-nitrosocysteineANLAAANCYKKEKHL
HHHHHHHCCCHHCCC
4.52-
160S-nitrosylationANLAAANCYKKEKHL
HHHHHHHCCCHHCCC
4.5219483679
162UbiquitinationLAAANCYKKEKHLDL
HHHHHCCCHHCCCCC
57.57-
162SumoylationLAAANCYKKEKHLDL
HHHHHCCCHHCCCCC
57.57-
162SumoylationLAAANCYKKEKHLDL
HHHHHCCCHHCCCCC
57.57-
1622-HydroxyisobutyrylationLAAANCYKKEKHLDL
HHHHHCCCHHCCCCC
57.57-
162AcetylationLAAANCYKKEKHLDL
HHHHHCCCHHCCCCC
57.5725953088
165UbiquitinationANCYKKEKHLDLEKN
HHCCCHHCCCCCCHH
59.35-
171AcetylationEKHLDLEKNWMLVEK
HCCCCCCHHHHHHHH
64.3126822725
171UbiquitinationEKHLDLEKNWMLVEK
HCCCCCCHHHHHHHH
64.31-
1782-HydroxyisobutyrylationKNWMLVEKARVCYIA
HHHHHHHHHHEEEEE
33.73-
183PhosphorylationVEKARVCYIAGFFLT
HHHHHEEEEEEEEEE
7.3126546556
239 (in isoform 2)Ubiquitination-27.8421906983
246PhosphorylationGNETEAATFAREQGF
CCCHHHHHHHHHCCC
25.5246159829
256UbiquitinationREQGFETKDIKEIAK
HHCCCCCHHHHHHHH
50.702190698
256 (in isoform 1)Ubiquitination-50.7021906983
256AcetylationREQGFETKDIKEIAK
HHCCCCCHHHHHHHH
50.7026051181
259UbiquitinationGFETKDIKEIAKKTQ
CCCCHHHHHHHHHHC
53.88-
264UbiquitinationDIKEIAKKTQALPKM
HHHHHHHHHCCCHHC
36.53-
270AcetylationKKTQALPKMNSKRQR
HHHCCCHHCCCCCCE
52.118242835
274AcetylationALPKMNSKRQRIVIF
CCHHCCCCCCEEEEE
47.7719814873
290SulfoxidationQGRDDTIMATESEVT
CCCCCEEEEECCCEE
4.0230846556
312PhosphorylationDQKEIIDTNGAGDAF
CHHHHHCCCCCCCHH
25.7422817901
329PhosphorylationGFLSQLVSDKPLTEC
HHHHHHCCCCCHHHH
48.8122817901
342PhosphorylationECIRAGHYAASIIIR
HHHHHHHHHHEEEHH
11.7127642862
353S-nitrosylationIIIRRTGCTFPEKPD
EEHHCCCCCCCCCCC
3.3324105792
358AcetylationTGCTFPEKPDFH---
CCCCCCCCCCCC---
50.5626822725

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ADK_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ADK_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ADK_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FICD_HUMANFICDphysical
21988832
PORED_HUMANSRD5A3physical
21988832
NNMT_HUMANNNMTphysical
26344197
NQO1_HUMANNQO1physical
26344197
PCBP1_HUMANPCBP1physical
26344197
PIPNB_HUMANPITPNBphysical
26344197
RBM12_HUMANRBM12physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
614300Hypermethioninemia due to adenosine kinase deficiency (HMAKD)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB01048Abacavir
DB00640Adenosine
DB00131Adenosine monophosphate
DB00171Adenosine triphosphate
DB00811Ribavirin
Regulatory Network of ADK_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Identification of the phosphotyrosine proteome from thrombinactivated platelets.";
Maguire P.B., Wynne K.J., Harney D.F., O'Donoghue N.M., Stephens G.,Fitzgerald D.J.;
Proteomics 2:642-648(2002).
Cited for: PHOSPHORYLATION AT TYR-77.

TOP